Company Analysis
Sign in

Onconetix, Inc. (ONCO)

Nasdaq: ONCO · Pharmaceutical Preparations · Cincinnati, OH · filing with the SEC since 2019
Full chart Alerts Compare
Grade3.3
◀ Past 2.8● Present 2.4▶ Future 4.5
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Report filedMar 13, 2026Jun 2, 2025Apr 11, 2024Mar 9, 2023Mar 31, 2022
Revenue815,3712,524,11658,465··
Cost of revenue182,4581,469,0181,185,630··
Gross profit632,9131,055,098-1,127,165··
Research and development·154,3591,949,4064,129,6881,325,030
Selling, general and administrative7,043,90211,231,98214,770,6789,351,552·
General and administrative···9,351,5522,092,304
Total operating expenses18,489,76957,543,85334,907,43013,481,2403,417,334
Total costs and expenses35,00035,000···
Operating income-17,856,856-56,488,755-36,034,595-13,481,240-3,417,334
Interest expense751,005873,433671,625··
Interest and investment income218···
Other income (expense), net226,041168,746-1,387,69261,410·
Total non-operating income (expense)3,825,039-3,247,448-1,387,692··
Income before income taxes-14,031,817-59,736,203-37,422,287-13,419,830·
Income tax expense525-1,045,180-12,5933,158,873,000,000675,730,000,000
Net income including non-controlling interests··-37,409,694-13,419,830·
Net income-14,032,342-58,691,023-37,409,694-13,419,830-3,417,334
Preferred dividends···96,359·
Net income to common shareholders-15,530,937-58,897,427-37,409,694-13,516,189-4,044,725
Earnings per share, basic-16.56-1,823.39r-7,433.25rb-3,740.00b-4,284.00b
Earnings per share, diluted-16.56-1,823.39r-7,433.25rb-3,740.00b-4,284.00b
Weighted average shares, basic937,69032,301r5,033rb3,609b941b
Weighted average shares, diluted937,69032,301r5,033rb3,609b941b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-85 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton ONCO · research, not advice